RSS_IDENT_s_31372592_b_1_2_22
 2.21 Quantitative real‐time PCR analysis Total RNA was extracted from cells using Trizol (Invitrogen). Complementary DNA (cDNA) was synthesized from 2 μg of total RNA using the Super‐Script II First‐Strand Synthesis System (Invitrogen). mRNA levels were measured using quantitative real‐time PCR. The glyceraldehyde‐3‐phosphate dehydrogenase (Gapdh) gene was used as an endogenous control. The sequences of the primers used to target various genes are shown in Table 2. Details of the reaction system and amplification procedures have been described previously.24 Table 2 List of Human Inflammatory Cytokines Examined Using the Antibody Array (R&D Systems) Coordinate Analyte/Control Entrez Gene ID Alternate Nomenclature A1, A2 Reference Spots N/A RS A3, A4 Adiponectin 9370 Acrp30 A5, A6 Apolipoprotein A‐I 335 ApoA1 A7, A8 Angiogenin 283 ______ A9, A10 Angiopoietin‐1 284 Ang‐1, ANGPT1 A11, A12 Angiopoietin‐2 285 Ang‐2, ANGPT2 A13, A14 BAFF 10673 BLyS, TNFSF13B A15, A16 BDNF 627 Brain‐derived Neurotrophic Factor A17, A18 Complement Component C5/C5a 727 C5/C5a A19, A20 CD14 929 ______ A21, A22 CD30 943 TNFRSF8 A23, A24 Reference Spots N/A RS B3, B4 CD40 ligand 959 CD40L, TNFSF5, CD154, TRAP B5, B6 Chitinase 3‐like 1 1116 CHI3L1, YKL‐40 B7, B8 Complement Factor D 1675 Adipsin, CFD B9, B10 C‐Reactive Protein 1401 CRP B11, B12 Cripto‐1 6997 Teratocarcinoma‐derived Growth Factor B13, B14 Cystatin C 1471 CST3, ARMD11 B15, B16 Dkk‐1 22943 Dickkopf‐1 B17, B18 DPPIV 1803 CD26, DPP4, Dipeptidyl‐peptidase IV B19, B20 EGF 1950 Epidermal Growth Factor B21, B22 Emmprin 682 CD147, Basigin C3, C4 ENA‐78 6374 CXCL5 C5, C6 Endoglin 2022 CD105, ENG C7, C8 Fas Ligand 356 TNFSF6, CD178, CD95L C9, C10 FGF basic 2247 FGF‐2 C11, C12 FGF‐7 2252 KGF C13, C14 FGF‐19 9965 ______ C15, C16 Flt‐3 Ligand 2323 FLT3LG C17, C18 G‐CSF 1440 CSF3 C19, C20 GDF‐15 9518 MIC‐1 C21, C22 GM‐CSF 1437 CSF2 D1, D2 GROα 2919 CXCL1, MSGA‐α D3, D4 Growth Hormone 2688 GH, Somatotropin D5, D6 HGF 3082 Scatter Factor, SF D7, D8 ICAM‐1 3383 CD54 D9, D10 IFN‐γ 3458 IFNG D11, D12 IGFBP‐2 3485 ______ John Wiley & Sons, Ltd.
